We clearly showed that there are cell line specific on-target effects; for example, the siRNA targeting CCDC136 is very potent in PANC-1 cells but has limited or no effect in other tested pancreatic cancer cell lines, which includes HPAF-II, Mia PaCa-2, and AsPC-1 cells. This evidence concerns the gene CCDC136 and pancreatic neoplasm.